Cargando…

Use of a molecular bacterial load assay to distinguish between active TB and post-TB lung disease

Detalles Bibliográficos
Autores principales:	Mbelele, P. M., Sabiiti, W., Heysell, S. K., Sauli, E., Mpolya, E. A., Mfinanga, S., Gillespie, S. H., Addo, K. K., Kibiki, G., Sloan, D. J., Mpagama, S. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Union Against Tuberculosis and Lung Disease 2022
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886960/ https://www.ncbi.nlm.nih.gov/pubmed/35197168 http://dx.doi.org/10.5588/ijtld.21.0459

Ejemplares similares

TB or not TB? Definitive determination of species within the M ycobacterium tuberculosis complex in unprocessed sputum from adults with presumed multidrug‐resistant tuberculosis
por: Mbelele, Peter M., et al.
Publicado: (2021)

Mycobactericidal Effects of Different Regimens Measured by Molecular Bacterial Load Assay among People Treated for Multidrug-Resistant Tuberculosis in Tanzania
por: Mbelele, Peter M., et al.
Publicado: (2021)

Meta-Narrative Review of Molecular Methods for Diagnosis and Monitoring of Multidrug-Resistant Tuberculosis Treatment in Adults
por: Mbelele, Peter M., et al.
Publicado: (2018)

Gridlock from diagnosis to treatment of multidrug resistant tuberculosis (MDR-TB) in Tanzania: patients’ perspectives from a focus group discussion
por: Mpagama, Stellah G., et al.
Publicado: (2020)

Gridlock from diagnosis to treatment of multidrug-resistant tuberculosis in Tanzania: low accessibility of molecular diagnostic services and lack of healthcare worker empowerment in 28 districts of 5 high burden TB regions with mixed methods evaluation
por: Mpagama, Stellah G., et al.
Publicado: (2019)

Gridlock from Diagnosis to Treatment of Multidrug-Resistant Tuberculosis (MDR-TB) in Tanzania: Illuminating Potential Factors for Possible Intervention
por: Liyoyo, Alphonce A, et al.
Publicado: (2017)

Pharmacodynamic Biomarkers for Quantifying the Mycobacterial Effect of High Doses of Rifampin in Patients with Rifampin-susceptible Pulmonary Tuberculosis
por: Said, Bibie N, et al.
Publicado: (2021)

Atripla(R)/anti-TB combination in TB/HIV patients. Drug in focus
por: Semvua, Hadija H, et al.
Publicado: (2011)

Levofloxacin pharmacokinetics in saliva as measured by a mobile microvolume UV spectrophotometer among people treated for rifampicin-resistant TB in Tanzania
por: Mohamed, Sagal, et al.
Publicado: (2021)

Diagnostic Opportunities for Optimizing Management of Multidrug-Resistant Tuberculosis (MDR-TB) in Tanzania
por: Mpagama, Stellah G
Publicado: (2018)

Tuberculosis Molecular Bacterial Load Assay Reveals Early Delayed Bacterial Killing in Patients With Relapse
por: Ntinginya, Nyanda Elias, et al.
Publicado: (2022)

Performance of Tuberculosis Molecular Bacterial Load Assay Compared to Alere TB-LAM in Urine of Pulmonary Tuberculosis Patients with HIV Co-Infections
por: Mapamba, Daniel Adon, et al.
Publicado: (2023)

Whole genome sequencing-based drug resistance predictions of multidrug-resistant Mycobacterium tuberculosis isolates from Tanzania
por: Mbelele, Peter M., et al.
Publicado: (2022)

Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania
por: Mpagama, Stellah G., et al.
Publicado: (2023)

Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB
por: Shenai, Shubhada, et al.
Publicado: (2016)

Detection and Quantification of Viable Mycobacterium tuberculosis Bacilli in Saline-Processed Stool Samples by Tuberculosis Molecular Bacterial Load Assay: a Potential Alternative for Processing Stool
por: Musisi, Emmanuel, et al.
Publicado: (2022)

Post-TB health and wellbeing
por: Nightingale, R., et al.
Publicado: (2023)

Evaluation of the Antibody in Lymphocyte Supernatant Assay to Detect Active Tuberculosis
por: Sariko, Margaretha, et al.
Publicado: (2017)

Effectiveness of the Novel Anti-TB Bedaquiline against Drug-Resistant TB in Africa: A Systematic Review of the Literature
por: Traoré, Afsatou Ndama, et al.
Publicado: (2022)

TB Anywhere is TB Everywhere
por: Wortham, Jonathan M.
Publicado: (2018)

TB or not TB! That’s the question
por: Nugud, Ahmed, et al.
Publicado: (2019)

Beyond the Numbers: Interpreting WHO's Global Tuberculosis Report 2016 to Inform TB Policy and Practice in the East African Community
por: Sabiiti, Wilber
Publicado: (2017)

Clinical standards for the dosing and management of TB drugs
por: Alffenaar, J. W. C., et al.
Publicado: (2022)

Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis Molecular Bacterial Load Assay
por: Sabiiti, Wilber, et al.
Publicado: (2020)

Combination of Blood Routine Examination and T-SPOT.TB Assay for Distinguishing Between Active Tuberculosis and Latent Tuberculosis Infection
por: Luo, Ying, et al.
Publicado: (2021)

Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania
por: Mpagama, Stellah G, et al.
Publicado: (2013)

The meta-analysis for ideal cytokines to distinguish the latent and active TB infection
por: Wei, Zhenhong, et al.
Publicado: (2020)

Multiple Pathogens Contribute to Human Immunodeficiency Virus-Related Sepsis in Addition to Mycobacterium tuberculosis: A Prospective Cohort in Tanzania
por: Tsere, Donatus Bonphace, et al.
Publicado: (2022)

Prospective evaluation of simply modified MODS assay: an effective tool for TB diagnosis and detection of MDR-TB
por: Chaiyasirinroje, Boonchai, et al.
Publicado: (2012)

The TAM-TB Assay—A Promising TB Immune-Diagnostic Test With a Potential for Treatment Monitoring
por: Ahmed, Mohamed I. M., et al.
Publicado: (2019)

Early detection of Pre-XDR TB with line probe assay in a high TB burden country
por: Madukaji, Laura, et al.
Publicado: (2021)

Therapeutic drug monitoring and TB treatment outcomes in patients with diabetes mellitus
por: Alkabab, Y., et al.
Publicado: (2023)

Implementation of evidence-based multiple focus integrated intensified TB screening to end TB (EXIT-TB) package in East Africa: a qualitative study
por: Isangula, Kahabi, et al.
Publicado: (2023)

Striking the Right Balance Determines TB or Not TB
por: BoseDasgupta, Somdeb, et al.
Publicado: (2014)

Improved performance of Xpert MTB/RIF assay on sputum sediment samples obtained from presumptive pulmonary tuberculosis cases at Kibong’oto infectious diseases hospital in Tanzania
por: Mbelele, Peter M., et al.
Publicado: (2017)

Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function
por: Allwood, B. W., et al.
Publicado: (2021)

Clinical standards for the management of adverse effects during treatment for TB
por: Singh, K. P., et al.
Publicado: (2023)

A Toolbox for Tuberculosis (TB) Diagnosis: An Indian Multi-Centric Study (2006-2008); Evaluation of Serological Assays Based on PGL-Tb1 and ESAT-6/CFP10 Antigens for TB Diagnosis
por: Lagrange, Philippe H., et al.
Publicado: (2014)

Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now
por: Chowdhury, Kona, et al.
Publicado: (2023)

The TB REACH Initiative: Supporting TB Elimination Efforts in the Asia-Pacific
por: Creswell, Jacob, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jgmk4d66g920v96e0mpknapt1o